PubMed:32603531 / 0-244
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 49-57 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 59-60 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
| T2 | 93-96 | http://purl.obolibrary.org/obo/PR_000001343 | denotes | aim |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T1 | 151-161 | Chemical | denotes | febuxostat | http://purl.obolibrary.org/obo/CHEBI_31596 |
| T2 | 187-205 | Chemical | denotes | hydroxychloroquine | http://purl.obolibrary.org/obo/CHEBI_5801 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-58 | Sentence | denotes | Febuxostat therapy in outpatients with suspected COVID-19: |
| T2 | 59-76 | Sentence | denotes | A clinical trial. |
| T3 | 77-88 | Sentence | denotes | BACKGROUND: |